Meridian Bioscience (NASDAQ:VIVO): Q1 Non-GAAP EPS of $0.10 beats by $0.04; GAAP EPS of $0.07 beats by $0.01.
Revenue of $47.42M (-7.9% Y/Y) misses by $1.29M.
https://seekingalpha.com/news/3539650-meridian-bioscience-eps-beats-0_04-misses-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.